CN Patent

CN101679409B — 双环杂环衍生化合物、其医药组合物和其用途

Assigned to Astex Therapeutics Ltd · Expires 2014-11-26 · 11y expired

What this patent protects

本发明涉及新颖双环杂环衍生化合物、包含所述化合物的医药组合物和所述化合物用于治疗疾病如癌症的用途。

USPTO Abstract

本发明涉及新颖双环杂环衍生化合物、包含所述化合物的医药组合物和所述化合物用于治疗疾病如癌症的用途。

Drugs covered by this patent

infigratinib-phosphate (INFIGRATINIB PHOSPHATE)

Patent Metadata

Patent number: CN101679409B
Jurisdiction: CN
Classification: —
Expires: 2014-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Astex Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.